{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:14:39Z","timestamp":1790280879843,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bill & Melinda Gates Foundation","award":["OPP1043501"],"award-info":[{"award-number":["OPP1043501"]}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cbpa.2019.01.029","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T08:13:49Z","timestamp":1552378429000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The antimalarial screening landscape\u2014looking beyond the asexual blood stage"],"prefix":"10.1016","volume":"50","author":[{"given":"Sabrina","family":"Yahiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainoa","family":"Rueda-Zubiaurre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Delves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Fuchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2019.01.029_bib0005","series-title":"Press Release","article-title":"World malaria report 2017","year":"2017"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1475-2875-11-316","article-title":"The global pipeline of new medicines for the control and elimination of malaria","volume":"11","author":"Anthony","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1473-3099(15)00423-5","article-title":"Potential for reduction of burden and local elimination of malaria by reducing plasmodium falciparum malaria transmission: a mathematical modelling study","volume":"16","author":"Griffin","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002456","article-title":"Malera: an updated research agenda for malaria elimination and eradication","volume":"14","author":"Rabinovich","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery - approaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0040","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(13)60024-0","article-title":"Malaria","volume":"383","author":"White","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0045","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pt.2016.04.014","article-title":"Phenotypic screens in antimalarial drug discovery","volume":"32","author":"Hovlid","year":"2016","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0050","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/biot.200900007","article-title":"Automated classification of plasmodium sporozoite movement patterns reveals a shift towards productive motility during salivary gland infection","volume":"4","author":"Hegge","year":"2009","journal-title":"Biotechnol J"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chom.2015.12.001","article-title":"High-throughput assay and discovery of small molecules that interrupt malaria transmission","volume":"19","author":"Plouffe","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0060","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1128\/AAC.03666-14","article-title":"A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs","volume":"58","author":"Ruecker","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0065","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ijpara.2012.08.009","article-title":"A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines","volume":"42","author":"Delves","year":"2012","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0070","article-title":"A comprehensive model for assessment of liver stage therapies targeting plasmodium vivax and plasmodium falciparum","volume":"9","author":"Roth","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0075","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The chembl database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0080","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical genetics of plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1475-2875-13-190","article-title":"Screening and hit evaluation of a chemical library against blood-stage plasmodium falciparum","volume":"13","author":"Avery","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149996","article-title":"Biochemical screening of five protein kinases from plasmodium falciparum against 14,000 cell-active compounds","volume":"11","author":"Crowther","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15160","article-title":"Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screen","volume":"8","author":"Miguel-Blanco","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijpddr.2018.04.007","article-title":"Functional screening of selective mitochondrial inhibitors of plasmodium","volume":"8","author":"Gomez-Lorenzo","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0115","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/AAC.02110-15","article-title":"Discovery of dual-stage malaria inhibitors with new targets","volume":"60","author":"Raphemot","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","article-title":"Spiroindolone kae609 for falciparum and vivax malaria","volume":"371","author":"White","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/2047773215Y.0000000013","article-title":"Killing the hypnozoite-drug discovery approaches to prevent relapse in plasmodium vivax","volume":"109","author":"Campo","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0130","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2960","article-title":"A pre-emptive strike against malaria\u2019s stealthy hepatic forms","volume":"8","author":"Mazier","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.chom.2013.06.005","article-title":"A microscale human liver platform that supports the hepatic stages of plasmodium falciparum and vivax","volume":"14","author":"March","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0140","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0145","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa1602250","article-title":"Antimalarial activity of kaf156 in falciparum and vivax malaria","volume":"375","author":"White","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0150","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/infdis\/jis184","article-title":"Drug screen targeted at plasmodium liver stages identifies a potent multistage antimalarial drug","volume":"205","author":"da Cruz","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acsinfecdis.5b00143","article-title":"High-throughput luciferase-based assay for the discovery of therapeutics that prevent malaria","volume":"2","author":"Swann","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006440","article-title":"Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria","volume":"12","author":"Watson","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018162","article-title":"Towards an in vitro model of plasmodium hypnozoites suitable for drug discovery","volume":"6","author":"Dembele","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0170","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.01927-13","article-title":"Kai407, a potent non-8-aminoquinoline compound that kills plasmodium cynomolgi early dormant liver stage parasites in vitro","volume":"58","author":"Zeeman","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.3461","article-title":"Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures","volume":"20","author":"Dembele","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0180","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","article-title":"Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice","volume":"17","author":"Mikolajczak","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0185","doi-asserted-by":"crossref","first-page":"16708","DOI":"10.1073\/pnas.1205414109","article-title":"Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in plasmodium falciparum","volume":"109","author":"Malmquist","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006336","article-title":"Developing transmission-blocking strategies for malaria control","volume":"13","author":"Sinden","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijpara.2012.02.004","article-title":"Malaria parasite colonisation of the mosquito midgut--placing the plasmodium ookinete centre stage","volume":"42","author":"Angrisano","year":"2012","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1473-3099(18)30163-4","article-title":"Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in kenyan adults with uncomplicated malaria (ivermal): a randomised, double-blind, placebo-controlled trial","volume":"18","author":"Smit","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0205","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1475-2875-12-153","article-title":"Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination","volume":"12","author":"Chaccour","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.pt.2014.07.004","article-title":"Defining the biology component of the drug discovery strategy for malaria eradication","volume":"30","author":"Leroy","year":"2014","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0215","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/nprot.2016.096","article-title":"Routine in vitro culture of p. Falciparum gametocytes to evaluate novel transmission-blocking interventions","volume":"11","author":"Delves","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0220","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nprot.2015.072","article-title":"An assay to probe plasmodium falciparum growth, transmission stage formation and early gametocyte development","volume":"10","author":"Brancucci","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0225","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nprot.2016.056","article-title":"Large-scale production of plasmodium falciparum gametocytes for malaria drug discovery","volume":"11","author":"Duffy","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0230","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of inhibitors of plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0235","doi-asserted-by":"crossref","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative assessment of plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue","volume":"108","author":"Adjalley","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0240","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/infdis\/jir037","article-title":"A high-throughput screen targeting malaria transmission stages opens new avenues for drug development","volume":"203","author":"Buchholz","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molbiopara.2011.09.002","article-title":"A high-throughput assay for the identification of drugs against late-stage plasmodium falciparum gametocytes","volume":"180","author":"Peatey","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035019","article-title":"Activity of clinically relevant antimalarial drugs on plasmodium falciparum mature gametocytes in an atp bioluminescence \u201ctransmission blocking\u201d assay","volume":"7","author":"Lelievre","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135139","article-title":"A new set of chemical starting points with plasmodium falciparum transmission-blocking potential for antimalarial drug discovery","volume":"10","author":"Almela","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0260","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/jac\/dkt165","article-title":"A plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection","volume":"68","author":"D\u2019Alessandro","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0265","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molbiopara.2011.02.005","article-title":"A malaria gametocytocidal assay using oxidoreduction indicator, alamarblue","volume":"177","author":"Tanaka","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0270","doi-asserted-by":"crossref","DOI":"10.1038\/srep16414","article-title":"A simple and predictive phenotypic high content imaging assay for plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds","volume":"5","author":"Lucantoni","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0275","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijpara.2012.09.002","article-title":"Measuring the blockade of malaria transmission--an analysis of the standard membrane feeding assay","volume":"42","author":"Churcher","year":"2012","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0280","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12936-015-0665-8","article-title":"Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against plasmodium falciparum","volume":"14","author":"Li","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0285","doi-asserted-by":"crossref","first-page":"18704","DOI":"10.1038\/srep18704","article-title":"A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes","volume":"5","author":"Vos","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0290","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S1473-3099(15)00479-X","article-title":"Primaquine to reduce transmission of plasmodium falciparum malaria in mali: A single-blind, dose-ranging, adaptive randomised phase 2 trial","volume":"16","author":"Dicko","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0295","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/AAC.00325-13","article-title":"Male and female plasmodium falciparum mature gametocytes show different responses to antimalarial drugs","volume":"57","author":"Delves","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182003003299","article-title":"Sex ratio of plasmodium falciparum gametocytes in inhabitants of dielmo, senegal","volume":"127","author":"Robert","year":"2003","journal-title":"Parasitology"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0305","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01426-18","article-title":"Gametocytes from k13-propeller mutant plasmodium falciparum clinical isolates demonstrate reduced susceptibility to dihydroartemisinin in the male gamete exflagellation inhibition assay","author":"Lozano","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0310","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/AAC.04684-14","article-title":"Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against plasmodium falciparum female gamete formation","volume":"59","author":"Miguel-Blanco","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26125-w","article-title":"Predicting transmission blocking potential of anti-malarial compounds in the mosquito feeding assay using plasmodium falciparum male gamete inhibition assay","volume":"8","author":"Colmenarejo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05777-2","article-title":"A high throughput screen for next-generation leads targeting malaria parasite transmission","volume":"9","author":"Delves","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2019.01.029_bib0325","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baragana","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2019.01.029_sbref0330","doi-asserted-by":"crossref","first-page":"eaat9446","DOI":"10.1126\/science.aat9446","article-title":"Open-source discovery of chemical leads for next-generation chemoprotective antimalarials","volume":"362","author":"Antonova-Koch","year":"2018","journal-title":"Science"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593118301480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593118301480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T02:42:39Z","timestamp":1761273759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593118301480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":66,"alternative-id":["S1367593118301480"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2019.01.029","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antimalarial screening landscape\u2014looking beyond the asexual blood stage","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2019.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}